Emory Seeks to Patent Cocaine Addiction Treatment

NS and MSP faculty member, David Weinshenker, PhD, was featured in the Atlanta Business Chronicle for his development of a treatmeant for cocaine addiction.

According to a patent application made public Oct. 17, the treatment was developed by researchers at Emory and Yale University. It works by giving patients a drug called a "dopamine beta-hydroxylase inhibitor" that both decreases the rewarding effects of cocaine and other stimulants while increasing the adverse effects of the drug.